Home/Filings/4/0001126234-24-000116
4//SEC Filing

Pitukcheewanont Pisit Duke 4

Accession 0001126234-24-000116

CIK 0001126234other

Filed

Dec 12, 7:00 PM ET

Accepted

Dec 13, 9:31 PM ET

Size

13.8 KB

Accession

0001126234-24-000116

Insider Transaction Report

Form 4
Period: 2024-12-12
Pitukcheewanont Pisit Duke
Chief Medical Officer
Transactions
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2024-12-1225,5000 total
    Exercise: $3.30Exp: 2033-07-01Common Stock (25,500 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2024-12-1229,7500 total
    Exercise: $7.69Exp: 2032-06-01Common Stock (29,750 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2024-12-1241,5000 total
    Exercise: $2.84Exp: 2034-03-31Common Stock (41,500 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2024-12-123,3330 total
    Exercise: $3.52Exp: 2033-02-01Common Stock (3,333 underlying)
  • Disposition to Issuer

    Common Stock

    2024-12-1216,8360 total
Footnotes (3)
  • [F1]Disposed of pursuant to that certain Agreement and Plan of Merger, dated October 22, 2024, by and between the Issuer, DPV Parent, Inc., DPV MergerSub, Inc. and Double Point Ventures LLC ("DPV") (the "Merger Agreement") in exchange for (i) $4.25 in cash per share (the "Cash Amount"), plus (ii) one non-transferable contingent value right ("CVR") per share. Each restricted stock unit ("RSU") was cancelled and will receive the Cash Amount plus one CVR per RSU.
  • [F2]This option was cancelled pursuant to the Merger Agreement in exchange for (i) an amount in cash equal to the product of (x) the total number of shares underlying such option multiplied by (y) the excess of the Cash Amount over the applicable exercise price per share and (ii) one CVR for each share underlying such in-the-money option.
  • [F3]Represents an out-of-money option that was cancelled without any cash payment or issuance of CVRs being made in respect thereof pursuant to the Merger Agreement.

Issuer

LUMOS PHARMA, INC.

CIK 0001126234

Entity typeother

Related Parties

1
  • filerCIK 0002006724

Filing Metadata

Form type
4
Filed
Dec 12, 7:00 PM ET
Accepted
Dec 13, 9:31 PM ET
Size
13.8 KB